BioCentury
ARTICLE | Company News

Biomira, Biovector Therapeutics SA deal

April 2, 2001 7:00 AM UTC

The companies terminated a 1998 co-development deal for BIOM's idiotypic vaccine against B cell lymphoma (see BioCentury, Sept. 28, 1998). BIOM said Biovector made a decision to focus on developing it...